Quantitative Investment Management, LLC Vanda Pharmaceuticals Inc. Transaction History

Quantitative Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $253,455 - $567,739	-33,794 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$12.38 - $17.47 $16,131 - $22,763	-1,303 Reduced 3.71%	33,794 $554,000
Q3 2019 Nov 14, 2019	SELL	$12.27 - $15.79 $27,644 - $35,574	-2,253 Reduced 6.03%	35,097 $466,000
Q2 2019 Aug 14, 2019	BUY	$13.37 - $18.85 $6,631 - $9,349	496 Added 1.35%	37,350 $526,000
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $648,261 - $1.14 Million	36,854 New	36,854 $678,000
Q3 2018 Nov 14, 2018	SELL	$18.25 - $23.0 $224,475 - $282,900	-12,300 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$13.95 - $19.15 $161,820 - $222,139	-11,600 Reduced 48.54%	12,300 $234,000
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $335,795 - $482,780	23,900 New	23,900 $402,000
Q4 2017 Feb 14, 2018	SELL	$12.85 - $18.1 $1.88 Million - $2.65 Million	-146,200 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$15.4 - $18.85 $2.25 Million - $2.76 Million	146,200	146,200 $2.62 Million

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $282M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.